301096 百誠醫藥
按盤價 
57.580 +2.680 (+4.882%)
57.580 +2.680 (+4.882%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.120 | -2.004 | 10.528 | 8.089 | 8.358 |
| 總資產報酬率 ROA (%) | 0.082 | -1.427 | 8.243 | 6.633 | 6.233 |
| 投入資產回報率 ROIC (%) | 0.086 | -1.542 | 8.966 | 7.062 | 6.632 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.735 | 51.982 | 65.528 | 67.373 | 67.265 |
| 營業利潤率 (%) | 1.109 | -4.289 | 29.193 | 31.057 | 31.789 |
| 息稅前利潤/營業總收入 (%) | 3.441 | -3.972 | 26.977 | 24.546 | 32.013 |
| 淨利潤/營業總收入 (%) | 0.932 | -6.600 | 26.735 | 31.946 | 29.646 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -107.781 | 22.084 | 102.449 | 90.733 | 96.330 |
| 價值變動淨收益/利潤總額(%) | 43.288 | 15.506 | -0.036 | -2.081 | -0.547 |
| 營業外收支淨額/利潤總額(%) | 5.506 | 4.624 | -0.454 | 1.185 | -0.035 | 償債能力分析 |
| 流動比率 (X) | 1.820 | 2.009 | 1.900 | 5.538 | 4.708 |
| 速動比率 (X) | 1.604 | 1.778 | 1.790 | 5.311 | 4.660 |
| 資產負債率 (%) | 33.355 | 30.684 | 26.845 | 15.273 | 20.756 |
| 帶息債務/全部投入資本 (%) | 27.834 | 22.861 | 15.212 | 3.570 | 12.664 |
| 股東權益/帶息債務 (%) | 249.431 | 321.431 | 529.979 | 2,540.417 | 662.769 |
| 股東權益/負債合計 (%) | 199.806 | 225.906 | 272.510 | 554.820 | 381.801 |
| 利息保障倍數 (X) | 1.518 | -7.575 | -12.943 | -3.566 | 135.989 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 221.043 | 126.015 | 61.820 | 67.053 | 53.508 |
| 存貨周轉天數 (天) | 210.612 | 126.454 | 81.715 | 80.748 | 38.888 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
